Nigora Mukhamedova1, Anh Hoang1, Huanhuan L Cui1, Irena Carmichael1, Ying Fu1, Michael Bukrinsky1, Dmitri Sviridov2. 1. From the Department of Lipoproteins and Atherosclerosis, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia (N.M., A.H., H.L.C., I.C., Y.F., D.S.); Department of Medicine, Karolinska Institute, Stockholm, Sweden (H.L.C.); and Department of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC (M.B.). 2. From the Department of Lipoproteins and Atherosclerosis, Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia (N.M., A.H., H.L.C., I.C., Y.F., D.S.); Department of Medicine, Karolinska Institute, Stockholm, Sweden (H.L.C.); and Department of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, DC (M.B.). Dmitri.Sviridov@bakeridi.edu.au.
Abstract
OBJECTIVE: ABCA1 (ATP-binding cassette transporter A1) is the principal protein responsible for cellular cholesterol efflux. Abundance and functionality of ABCA1 is regulated both transcriptionally and post-translationally, with endocytosis of ABCA1 being an important element of post-translational regulation. Functional ABCA1 resides on the plasma membrane but can be internalized and either degraded or recycled back to the plasma membrane. The interaction between the degradative and recycling pathways determines the abundance of ABCA1 and may contribute to the efflux of intracellular cholesterol. APPROACH AND RESULTS: Here, we show that the principal pathway responsible for the internalization of ABCA1 leading to its degradation in macrophages is ARF6-dependent endocytic pathway. This pathway was predominant in the regulation of ABCA1 abundance and efflux of plasma membrane cholesterol. Conversely, the efflux of intracellular cholesterol was predominantly controlled by ARF6-independent pathways, and inhibition of ARF6 shifted ABCA1 into recycling endosomes enhancing efflux of intracellular cholesterol. CONCLUSIONS: We conclude that ARF6-dependent pathway is the predominant route responsible for the ABCA1 internalization and degradation, whereas ARF6-independent endocytic pathways may contribute to ABCA1 recycling and efflux of intracellular cholesterol.
OBJECTIVE:ABCA1 (ATP-binding cassette transporter A1) is the principal protein responsible for cellular cholesterol efflux. Abundance and functionality of ABCA1 is regulated both transcriptionally and post-translationally, with endocytosis of ABCA1 being an important element of post-translational regulation. Functional ABCA1 resides on the plasma membrane but can be internalized and either degraded or recycled back to the plasma membrane. The interaction between the degradative and recycling pathways determines the abundance of ABCA1 and may contribute to the efflux of intracellular cholesterol. APPROACH AND RESULTS: Here, we show that the principal pathway responsible for the internalization of ABCA1 leading to its degradation in macrophages is ARF6-dependent endocytic pathway. This pathway was predominant in the regulation of ABCA1 abundance and efflux of plasma membrane cholesterol. Conversely, the efflux of intracellular cholesterol was predominantly controlled by ARF6-independent pathways, and inhibition of ARF6 shifted ABCA1 into recycling endosomes enhancing efflux of intracellular cholesterol. CONCLUSIONS: We conclude that ARF6-dependent pathway is the predominant route responsible for the ABCA1 internalization and degradation, whereas ARF6-independent endocytic pathways may contribute to ABCA1 recycling and efflux of intracellular cholesterol.
Authors: E B Neufeld; A T Remaley; S J Demosky; J A Stonik; A M Cooney; M Comly; N K Dwyer; M Zhang; J Blanchette-Mackie; S Santamarina-Fojo; H B Brewer Journal: J Biol Chem Date: 2001-05-10 Impact factor: 5.157
Authors: Loren E Faulkner; Stacey E Panagotopulos; Jacob D Johnson; Laura A Woollett; David Y Hui; Scott R Witting; J Nicholas Maiorano; W Sean Davidson Journal: J Lipid Res Date: 2008-03-22 Impact factor: 5.922
Authors: Edward B Neufeld; John A Stonik; Stephen J Demosky; Catherine L Knapper; Christian A Combs; Adele Cooney; Marcella Comly; Nancy Dwyer; Joan Blanchette-Mackie; Alan T Remaley; Silvia Santamarina-Fojo; H Bryan Brewer Journal: J Biol Chem Date: 2004-01-27 Impact factor: 5.157
Authors: Huanhuan L Cui; Belinda Guo; Benjamin Scicluna; Bradley M Coleman; Victoria A Lawson; Laura Ellett; Peter J Meikle; Michael Bukrinsky; Nigora Mukhamedova; Dmitri Sviridov; Andrew F Hill Journal: J Biol Chem Date: 2013-11-26 Impact factor: 5.157
Authors: Varun Rawat; Shaowei Wang; Jian Sima; Roni Bar; Ori Liraz; Usha Gundimeda; Trusha Parekh; Jamie Chan; Jan O Johansson; Chongren Tang; Helena C Chui; Michael G Harrington; Daniel M Michaelson; Hussein N Yassine Journal: J Neurosci Date: 2019-10-22 Impact factor: 6.167
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Nigora Mukhamedova; Anh Hoang; Dragana Dragoljevic; Larisa Dubrovsky; Tatiana Pushkarsky; Hann Low; Michael Ditiatkovski; Ying Fu; Ryunosuke Ohkawa; Peter J Meikle; Anelia Horvath; Beda Brichacek; Yury I Miller; Andrew Murphy; Michael Bukrinsky; Dmitri Sviridov Journal: PLoS Pathog Date: 2019-07-25 Impact factor: 6.823
Authors: Fadil M Hannan; Mark Stevenson; Asha L Bayliss; Victoria J Stokes; Michelle Stewart; Kreepa G Kooblall; Caroline M Gorvin; Gemma Codner; Lydia Teboul; Sara Wells; Rajesh V Thakker Journal: Hum Mol Genet Date: 2021-05-29 Impact factor: 6.150
Authors: Dmitri Sviridov; Nigora Mukhamedova; Alexander A Makarov; Alexei Adzhubei; Michael Bukrinsky Journal: AIDS Date: 2020-01-01 Impact factor: 4.632